Videx EC

Videx EC is a brand name for the medication Didanosine, which is an antiretroviral drug used in the treatment of Human Immunodeficiency Virus (HIV) infections. It is a type of medication known as a nucleoside reverse transcriptase inhibitor (NRTI), which works by slowing the spread of HIV in the body. Videx EC is manufactured by Bristol-Myers Squibb.

History[edit | edit source]

Videx EC was approved by the Food and Drug Administration (FDA) in the United States in 1991. It was one of the first antiretroviral drugs available for the treatment of HIV and was initially used in combination with other antiretroviral drugs.

Mechanism of Action[edit | edit source]

As a nucleoside reverse transcriptase inhibitor, Videx EC works by blocking the action of an enzyme called reverse transcriptase, which is used by HIV to replicate its genetic material and spread throughout the body. By inhibiting this enzyme, Videx EC helps to slow the progression of HIV infection.

Side Effects[edit | edit source]

Common side effects of Videx EC include nausea, diarrhea, and abdominal pain. More serious side effects can include pancreatitis and peripheral neuropathy. It is important for patients to discuss these potential side effects with their healthcare provider before starting treatment with Videx EC.

Dosage[edit | edit source]

Videx EC is available in capsule form and is typically taken once daily. The exact dosage will depend on the patient's weight and other factors, and should be determined by a healthcare provider.

Interactions[edit | edit source]

Videx EC can interact with a number of other medications, including other antiretroviral drugs. It is important for patients to inform their healthcare provider of all medications they are currently taking before starting treatment with Videx EC.